UniProt ID | ATF7_HUMAN | |
---|---|---|
UniProt AC | P17544 | |
Protein Name | Cyclic AMP-dependent transcription factor ATF-7 | |
Gene Name | ATF7 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 494 | |
Subcellular Localization |
Nucleus . Nucleus, nucleoplasm . Mainly nucleoplasmic. Restricted distribution to the perinuculear region. The sumoylated form locates to the nuclear periphery. Isoform 5: Cytoplasm . |
|
Protein Description | Plays important functions in early cell signaling. Binds the cAMP response element (CRE) (consensus: 5'-GTGACGT[AG][AG]-3'), a sequence present in many viral and cellular promoters. Activator of the NF-ELAM1/delta-A site of the E-selectin promoter. Has no intrinsic transcriptional activity, but activates transcription on formation of JUN or FOS heterodimers. Also can bind TRE promoter sequences when heterodimerized with members of the JUN family.; Isoform 4 acts as a dominant repressor of the E-selectin/NF-ELAM1/delta-A promoter.; Isoform 5 acts as a negative regulator, inhibiting both ATF2 and ATF7 transcriptional activities. It may exert these effects by sequestrating in the cytoplasm the Thr-53 phosphorylating kinase, preventing activation.. | |
Protein Sequence | MGDDRPFVCNAPGCGQRFTNEDHLAVHKHKHEMTLKFGPARTDSVIIADQTPTPTRFLKNCEEVGLFNELASSFEHEFKKAADEDEKKARSRTVAKKLVAAAGPLDMSLPSTPDIKIKEEEPVEVDSSPPDSPASSPCSPPLKEKEVTPKPVLISTPTPTIVRPGSLPLHLGYDPLHPTLPSPTSVITQAPPSNRQMGSPTGSLPLVMHLANGQTMPVLPGPPVQMPSVISLARPVSMVPNIPGIPGPPVNSSGSISPSGHPIPSEAKMRLKATLTHQVSSINGGCGMVVGTASTMVTARPEQSQILIQHPDAPSPAQPQVSPAQPTPSTGGRRRRTVDEDPDERRQRFLERNRAAASRCRQKRKLWVSSLEKKAEELTSQNIQLSNEVTLLRNEVAQLKQLLLAHKDCPVTALQKKTQGYLESPKESSEPTGSPAPVIQHSSATAPSNGLSVRSAAEAVATSVLTQMASQRTELSMPIQSHVIMTPQSQSAGR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
34 | Phosphorylation | HKHKHEMTLKFGPAR EECCCEEEEEECCCC | 24.66 | 22304920 | |
42 | Phosphorylation | LKFGPARTDSVIIAD EEECCCCCCCEEEEC | 34.43 | 28176443 | |
44 | Phosphorylation | FGPARTDSVIIADQT ECCCCCCCEEEECCC | 18.01 | 23401153 | |
51 | Phosphorylation | SVIIADQTPTPTRFL CEEEECCCCCCCHHH | 29.67 | 29255136 | |
53 | Phosphorylation | IIADQTPTPTRFLKN EEECCCCCCCHHHHC | 40.45 | 29255136 | |
55 | Phosphorylation | ADQTPTPTRFLKNCE ECCCCCCCHHHHCHH | 36.21 | 29255136 | |
59 | Ubiquitination | PTPTRFLKNCEEVGL CCCCHHHHCHHHCCH | 57.76 | 29967540 | |
72 | Phosphorylation | GLFNELASSFEHEFK CHHHHHHHHHHHHHH | 48.46 | 25849741 | |
73 | Phosphorylation | LFNELASSFEHEFKK HHHHHHHHHHHHHHH | 29.10 | 25849741 | |
79 | Ubiquitination | SSFEHEFKKAADEDE HHHHHHHHHHCCHHH | 38.22 | 29967540 | |
91 | Phosphorylation | EDEKKARSRTVAKKL HHHHHHHHHHHHHHH | 36.84 | 24702127 | |
93 | Phosphorylation | EKKARSRTVAKKLVA HHHHHHHHHHHHHHH | 26.51 | 24702127 | |
100 (in isoform 2) | Phosphorylation | - | 11.30 | 29507054 | |
101 | Phosphorylation | VAKKLVAAAGPLDMS HHHHHHHHHCCCCCC | 12.89 | 18950637 | |
101 (in isoform 2) | Phosphorylation | - | 12.89 | 29743597 | |
108 | Phosphorylation | AAGPLDMSLPSTPDI HHCCCCCCCCCCCCC | 36.47 | 29255136 | |
111 | Phosphorylation | PLDMSLPSTPDIKIK CCCCCCCCCCCCCCC | 58.84 | 30266825 | |
112 | Phosphorylation | LDMSLPSTPDIKIKE CCCCCCCCCCCCCCC | 24.04 | 29255136 | |
118 | Sumoylation | STPDIKIKEEEPVEV CCCCCCCCCCCCCCC | 54.81 | 17264123 | |
118 | Sumoylation | STPDIKIKEEEPVEV CCCCCCCCCCCCCCC | 54.81 | - | |
121 (in isoform 4) | Phosphorylation | - | 56.59 | 29116813 | |
124 (in isoform 4) | Phosphorylation | - | 51.85 | 29116813 | |
125 (in isoform 4) | Phosphorylation | - | 9.84 | 29116813 | |
127 | Phosphorylation | EEPVEVDSSPPDSPA CCCCCCCCCCCCCCC | 50.34 | 25159151 | |
128 | Phosphorylation | EPVEVDSSPPDSPAS CCCCCCCCCCCCCCC | 35.67 | 25159151 | |
132 | Phosphorylation | VDSSPPDSPASSPCS CCCCCCCCCCCCCCC | 28.30 | 25159151 | |
135 | Phosphorylation | SPPDSPASSPCSPPL CCCCCCCCCCCCCCC | 37.89 | 25159151 | |
136 | Phosphorylation | PPDSPASSPCSPPLK CCCCCCCCCCCCCCC | 31.84 | 25159151 | |
139 | Phosphorylation | SPASSPCSPPLKEKE CCCCCCCCCCCCCCC | 32.70 | 25022875 | |
148 | Phosphorylation | PLKEKEVTPKPVLIS CCCCCCCCCCCEEEE | 27.04 | 20068231 | |
155 | Phosphorylation | TPKPVLISTPTPTIV CCCCEEEECCCCCEE | 24.95 | 29978859 | |
156 | Phosphorylation | PKPVLISTPTPTIVR CCCEEEECCCCCEEC | 24.96 | 22496350 | |
158 | Phosphorylation | PVLISTPTPTIVRPG CEEEECCCCCEECCC | 32.90 | 20068231 | |
160 | Phosphorylation | LISTPTPTIVRPGSL EEECCCCCEECCCCC | 34.28 | 20068231 | |
166 | Phosphorylation | PTIVRPGSLPLHLGY CCEECCCCCCCCCCC | 29.51 | 28464451 | |
173 | Phosphorylation | SLPLHLGYDPLHPTL CCCCCCCCCCCCCCC | 22.28 | 28122231 | |
179 | Phosphorylation | GYDPLHPTLPSPTSV CCCCCCCCCCCCCCE | 40.32 | 28464451 | |
182 | Phosphorylation | PLHPTLPSPTSVITQ CCCCCCCCCCCEEEE | 43.87 | 25849741 | |
184 | Phosphorylation | HPTLPSPTSVITQAP CCCCCCCCCEEEECC | 39.71 | 25850435 | |
185 | Phosphorylation | PTLPSPTSVITQAPP CCCCCCCCEEEECCC | 18.20 | 28464451 | |
188 | Phosphorylation | PSPTSVITQAPPSNR CCCCCEEEECCCCCC | 19.27 | 25850435 | |
193 | Phosphorylation | VITQAPPSNRQMGSP EEEECCCCCCCCCCC | 43.52 | 25850435 | |
199 | Phosphorylation | PSNRQMGSPTGSLPL CCCCCCCCCCCCCCE | 17.59 | 28348404 | |
201 | Phosphorylation | NRQMGSPTGSLPLVM CCCCCCCCCCCCEEE | 40.89 | 28348404 | |
203 | Phosphorylation | QMGSPTGSLPLVMHL CCCCCCCCCCEEEEE | 29.32 | 28348404 | |
213 (in isoform 4) | Ubiquitination | - | 20.80 | 21890473 | |
227 | Phosphorylation | PGPPVQMPSVISLAR CCCCCCCCCCHHCCC | 14.35 | 32142685 | |
237 | Phosphorylation | ISLARPVSMVPNIPG HHCCCCCCCCCCCCC | 19.42 | 26074081 | |
248 | Phosphorylation | NIPGIPGPPVNSSGS CCCCCCCCCCCCCCC | 25.06 | 32142685 | |
252 | Phosphorylation | IPGPPVNSSGSISPS CCCCCCCCCCCCCCC | 35.99 | 26657352 | |
253 | Phosphorylation | PGPPVNSSGSISPSG CCCCCCCCCCCCCCC | 31.21 | 29255136 | |
255 | Phosphorylation | PPVNSSGSISPSGHP CCCCCCCCCCCCCCC | 23.11 | 26657352 | |
257 | Phosphorylation | VNSSGSISPSGHPIP CCCCCCCCCCCCCCC | 18.08 | 29255136 | |
259 | Phosphorylation | SSGSISPSGHPIPSE CCCCCCCCCCCCCCH | 42.83 | 29255136 | |
265 | Phosphorylation | PSGHPIPSEAKMRLK CCCCCCCCHHHHHHH | 51.40 | 29255136 | |
304 | Phosphorylation | VTARPEQSQILIQHP EEECHHHCCEEEECC | 19.95 | 29255136 | |
315 | Phosphorylation | IQHPDAPSPAQPQVS EECCCCCCCCCCCCC | 34.29 | 29255136 | |
322 | Phosphorylation | SPAQPQVSPAQPTPS CCCCCCCCCCCCCCC | 14.85 | 29255136 | |
327 | Phosphorylation | QVSPAQPTPSTGGRR CCCCCCCCCCCCCCC | 20.14 | 25850435 | |
330 | Phosphorylation | PAQPTPSTGGRRRRT CCCCCCCCCCCCCCC | 44.87 | - | |
334 | Ubiquitination | TPSTGGRRRRTVDED CCCCCCCCCCCCCCC | 35.39 | 32015554 | |
337 | Phosphorylation | TGGRRRRTVDEDPDE CCCCCCCCCCCCHHH | 30.42 | 29255136 | |
342 | Ubiquitination | RRTVDEDPDERRQRF CCCCCCCHHHHHHHH | 43.23 | 29967540 | |
358 | Phosphorylation | ERNRAAASRCRQKRK HHHHHHHHHHHHHHH | 27.47 | 22817900 | |
363 | Ubiquitination | AASRCRQKRKLWVSS HHHHHHHHHHHHHHH | 31.95 | 29967540 | |
368 | Ubiquitination | RQKRKLWVSSLEKKA HHHHHHHHHHHHHHH | 3.95 | 21890473 | |
368 (in isoform 2) | Ubiquitination | - | 3.95 | 21890473 | |
368 | Phosphorylation | RQKRKLWVSSLEKKA HHHHHHHHHHHHHHH | 3.95 | 32142685 | |
379 (in isoform 3) | Ubiquitination | - | 31.39 | 21890473 | |
389 | Ubiquitination | NIQLSNEVTLLRNEV CCCCHHHHHHHHHHH | 5.52 | 21890473 | |
389 | Ubiquitination | NIQLSNEVTLLRNEV CCCCHHHHHHHHHHH | 5.52 | 21890473 | |
400 (in isoform 1) | Ubiquitination | - | 27.16 | 21890473 | |
400 | Ubiquitination | RNEVAQLKQLLLAHK HHHHHHHHHHHHHCC | 27.16 | 32015554 | |
402 | Phosphorylation | EVAQLKQLLLAHKDC HHHHHHHHHHHCCCC | 3.96 | 32142685 | |
413 | Phosphorylation | HKDCPVTALQKKTQG CCCCCCHHHHHHHCC | 14.29 | 24275569 | |
418 | Phosphorylation | VTALQKKTQGYLESP CHHHHHHHCCCCCCC | 33.97 | 18669648 | |
421 | Phosphorylation | LQKKTQGYLESPKES HHHHHCCCCCCCCCC | 9.47 | 30576142 | |
423 | Phosphorylation | KKTQGYLESPKESSE HHHCCCCCCCCCCCC | 57.41 | 23186163 | |
424 | Phosphorylation | KTQGYLESPKESSEP HHCCCCCCCCCCCCC | 38.38 | 25159151 | |
428 | Phosphorylation | YLESPKESSEPTGSP CCCCCCCCCCCCCCC | 46.24 | 30266825 | |
429 | Phosphorylation | LESPKESSEPTGSPA CCCCCCCCCCCCCCC | 49.00 | 30266825 | |
432 | Phosphorylation | PKESSEPTGSPAPVI CCCCCCCCCCCCCEE | 46.36 | 23401153 | |
434 | Phosphorylation | ESSEPTGSPAPVIQH CCCCCCCCCCCEEEC | 21.99 | 29255136 | |
442 | Phosphorylation | PAPVIQHSSATAPSN CCCEEECCCCCCCCC | 12.80 | 23403867 | |
442 (in isoform 1) | O-linked_Glycosylation | - | 12.80 | 30059200 | |
443 | Phosphorylation | APVIQHSSATAPSNG CCEEECCCCCCCCCC | 27.75 | 23403867 | |
445 | Phosphorylation | VIQHSSATAPSNGLS EEECCCCCCCCCCCC | 40.84 | 23403867 | |
448 | Phosphorylation | HSSATAPSNGLSVRS CCCCCCCCCCCCHHH | 40.86 | 17081983 | |
452 | Phosphorylation | TAPSNGLSVRSAAEA CCCCCCCCHHHHHHH | 19.51 | 17081983 | |
455 (in isoform 1) | O-linked_Glycosylation | - | 29.67 | 30059200 | |
455 | O-linked_Glycosylation | SNGLSVRSAAEAVAT CCCCCHHHHHHHHHH | 29.67 | 30059200 | |
462 | O-linked_Glycosylation | SAAEAVATSVLTQMA HHHHHHHHHHHHHHH | 16.87 | 30059200 | |
463 (in isoform 1) | O-linked_Glycosylation | - | 12.85 | 30059200 | |
470 | Phosphorylation | SVLTQMASQRTELSM HHHHHHHHCCCCCCC | 18.17 | 26714015 | |
473 | Phosphorylation | TQMASQRTELSMPIQ HHHHHCCCCCCCCCC | 33.37 | 27251275 | |
476 | Phosphorylation | ASQRTELSMPIQSHV HHCCCCCCCCCCCEE | 19.11 | 27251275 | |
481 | Phosphorylation | ELSMPIQSHVIMTPQ CCCCCCCCEEEECCC | 22.05 | 27251275 | |
486 | Phosphorylation | IQSHVIMTPQSQSAG CCCEEEECCCHHCCC | 13.67 | 25159151 | |
489 | Phosphorylation | HVIMTPQSQSAGR-- EEEECCCHHCCCC-- | 27.57 | 27251275 | |
491 | Phosphorylation | IMTPQSQSAGR---- EECCCHHCCCC---- | 37.63 | 27251275 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
51 | T | Phosphorylation | Kinase | P38B | Q15759 | PSP |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ATF7_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TAF12_HUMAN | TAF12 | physical | 15735663 | |
TAF4_HUMAN | TAF4 | physical | 15735663 | |
CREB1_HUMAN | CREB1 | physical | 22939629 | |
MK08_HUMAN | MAPK8 | physical | 11566021 | |
OCAD1_HUMAN | OCIAD1 | physical | 20195357 | |
RMP_HUMAN | URI1 | physical | 20195357 | |
TAOK3_HUMAN | TAOK3 | physical | 20195357 | |
MITD1_HUMAN | MITD1 | physical | 20195357 | |
KASH5_HUMAN | CCDC155 | physical | 25416956 | |
FAM9B_HUMAN | FAM9B | physical | 25416956 | |
TM239_HUMAN | TMEM239 | physical | 25416956 | |
MBD3_HUMAN | MBD3 | physical | 21516116 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00852 | Pseudoephedrine |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-42; THR-51; THR-53;SER-108 AND THR-112, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-51; THR-53; THR-55 ANDSER-424, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-51; THR-53; SER-108 ANDTHR-112, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108 AND THR-112, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-51; THR-53; SER-111;THR-112; SER-127; SER-128; SER-132; SER-135; SER-136 AND SER-139, ANDMASS SPECTROMETRY. | |
"p38beta2-mediated phosphorylation and sumoylation of ATF7 aremutually exclusive."; Camuzeaux B., Diring J., Hamard P.J., Oulad-Abdelghani M., Donzeau M.,Vigneron M., Kedinger C., Chatton B.; J. Mol. Biol. 384:980-991(2008). Cited for: PHOSPHORYLATION AT THR-51; THR-53 AND THR-112, SUMOYLATION AT LYS-118,FUNCTION, AND MUTAGENESIS OF THR-51; THR-53; THR-112 AND LYS-118. |